mevalonic acid and Leukemia, Myeloid

mevalonic acid has been researched along with Leukemia, Myeloid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chorváth, B; Chovancová, J; Duraj, J; Hunáková, L; Sedlák, J; Suliková, M1
Dimitroulakos, J; Minden, MD; Penn, LZ; Tan, MM; Wong, WW; Xia, Z1

Other Studies

2 other study(ies) available for mevalonic acid and Leukemia, Myeloid

ArticleYear
Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin.
    Neoplasma, 1997, Volume: 44, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Drug Resistance, Multiple; HL-60 Cells; Humans; Leukemia, Myeloid; Lovastatin; Mevalonic Acid

1997
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Leukemia, 2001, Volume: 15, Issue:9

    Topics: Acute Disease; Apoptosis; Benzamides; Deoxyuracil Nucleotides; Fluorescein-5-isothiocyanate; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid; Lovastatin; Methionine; Mevalonic Acid; Polyisoprenyl Phosphates; Protein Prenylation; Sesquiterpenes; Tumor Cells, Cultured

2001